Nosopharm

Where the EU money came from

Funding by EU programme. Amounts are Nosopharm's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• GNA NOWPartner

  NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW

  Horizon 2020 · 2019–2026 · Project on CORDIS ↗

  €4.1Mtheir share
• ENABLEPartner

  European Gram Negative Antibacterial Engine

  FP7 (2007 to 2013) · 2014–2020 · Project on CORDIS ↗

  €1.2Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Helmholtz-Zentrum Fur Infektionsforschung GmbHGermany · 2 shared projects
• Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
• Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 1 shared project
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
• Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
• Kobenhavns UniversitetDenmark · 1 shared project
• Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
• Karolinska InstitutetSweden · 1 shared project
• Helsingin YliopistoFinland · 1 shared project
• Uppsala UniversitetSweden · 1 shared project
• Stichting VuNetherlands · 1 shared project
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project
• Universitat ZurichSwitzerland · 1 shared project
• Universitat de BarcelonaSpain · 1 shared project
• Rise Research Institutes of Sweden ABSweden · 1 shared project
• Medizinische Universitaet WienAustria · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• antibiotic resistance
• antibiotics
• bacteriology
• clinical microbiology
• drug discovery
• governance
• medicinal chemistry